• WeFund Health strives to improve wellness outcomes and prolong lives by commercializing healthcare innovations and connecting transformational companies with intelligent capital partners.

What We Do

WeFund Health is an international strategic advisory firm focused on market entry strategies,
direct investments, and platform-based industry-specific investment vehicles.

With headquarters in New York City, and presence in Europe, Russia, and China, we understand the
complexity of the ever-shifting global economy. For over 20 years we have been a part of this
robust and dynamic force, and understand the challenges it presents.

Rapidly evolving trends, regulatory obstacles, lack of access to capital on local markets, and myriad
of other barriers demand from businesses to have a nimble and facts-based strategy.

Our knowledge and agility are the two core principles in the way we approach business strategy
in both advisory and investment arms of the company.

We design business models based on:

• Knowledge of international markets attained from years of experience and access to a
unique network of experts in a wide spectrum of industries and verticals;

• Understanding of consumer, business, and technological trends;

• Proven methodology of aligning product, team, and the market cycle to foster growth;

• Access to the right relationships and strategic resources necessary for venture growth and

While our advisory practice works with a wide range of industry categories, our investment interests are focused in Biotech, Health Care and Wellness Technology and Communications, with a special emphasis on industry-specific platform solutions.


WeFund Health is an international business hub built on the foundation of long-standing
partnerships that drive unique opportunities, connections and business transactions. We leverage
our global community of recognized experts and advisors across a wide range of industries and
verticals. We partner with leading incubators, accelerators, brokerages, investment vehicles,
universities, and hospitals, in the United States, South America, Western and Eastern Europe, Israel,
and Asia. Decades of doing business on the international scale in both mature and emerging
markets have trusted relationships with deal flow partners, institutional and private investors, as
well as family offices from around the world.

Gained expertise, competencies and relationships help us structure our deals, tap new investment
opportunities, and facilitate market entry for our clients. That is why expanding our network and
forming new mutually beneficial partnerships is our business philosophy.

Whether you are an investor seeking new opportunities, a startup with a promising product, or
potential collaborator in Europe or Asia, we invite you to join the WeFund Health ecosystem today.

latest news

WeFund Health Partners with CureLab Oncology to Support International Clinical Trials of Novel Anti-Cancer Agent

WeFund Health Partners with CureLab Oncology to Support International Clinical Trials of Novel Anti-Cancer Agent

WeFund Health and CureLab Oncology, Inc. announced a partnership to provide comprehensive support of the international clinical trials on a novel anti-cancer immunoncoloy agent…

Shifting Momentum: Key Takeaways from the CPhI Worldwide Conference in Frankfurt, Germany

Shifting Momentum: Key Takeaways from the CPhI Worldwide Conference in Frankfurt, Germany

As a team actively involved in international licensing and commercialization projects, we have witnessed China consistently gaining stronger positions and surpassing its main competitors and…

WeFund Health and Premier Ocher Announce Partnership to Commercialize Chuda Cosmeceuticals

WeFund Health and Premier Ocher Announce Partnership to Commercialize Chuda Cosmeceuticals

WeFund Health, an international strategic advisory firm focused on market entry strategies, direct investments, and platform-based industry-specific investment vehicles, will support the commercialization of Premier Ocher’s cosmeceuticals brand of Chuda.

About Us


The WeFund Health management team provides significant expertise and industry relationships that play an integral role in the Company’s strategic growth plan.

  • Givi Topchishvili

    Givi Topchishvili

    Managing Director, Chief Executive Officer

    Serial entrepreneur with 20+ years of market entry experience in Europe, Asia, and the US, bringing over 100 brands to the US market and contributing to the first IPO in the history of Russia. Givi has extensive experience in venture capital, business strategy, and has authored multiple books and patents on marketing. 

  • Michael DePalma

    Michael DePalma

    Managing Director, Digital Health & Innovations

    A scientist by education, a technologist by vocation; 17 years of executive level strategic, technical, and business development experience in Health, Healthtech, Digital Health, and Life Sciences; TED speaker, co-founder of The Human API, former editor of BrainfoodTV.com, co-author of “The Blockchain Effect.”

  • Robert Gordonoff

    Robert Gordonoff

    Managing Director, Investment Strategy

    20 years on Wall Street, 12 years at Goldman Sachs. Held various executive, management and advisory positions in the areas of Asset Management, Risk Management, Equity Derivatives and Research, Algorithmic Trading and Regulatory Compliance. MS from Columbia University and MBA from NYU Stern.

  • Alex Romanovich

    Alex Romanovich

    Managing Director, Partner & Channel Development

    Marketer and business developer with strong background in designing, deploying and managing marketing and client acquisition platforms, as well as business intelligence solutions for IBM, Bertelsmann AG, SGI, SAP, Lufthansa, JP Morgan Chase, American Express and others.

  • Algirdas J. Lukosevicius

    Algirdas J. Lukosevicius

    Managing Director, Life Sciences

    Dr. Lukosevicius is a life sciences and healthcare business professional with deep knowledge and an extensive international experience; former pharma executive at Merck, Pfizer, Yale New Haven Hospital and Ernst & Young.

  • Alex Topchishvili

    Alex Topchishvili

    Managing Director, Marketing

    Marketing, branding, and lead generation expert with a passion for leveraging technology and new regulations in the private securities markets to connect innovative companies with investors; Former CMO at PotBotics and Marketing Strategist at AdoTube.

  • Dmitry Grinberg

    Dmitry Grinberg

    Managing Director, Technology

    Software architect with 20+ years experience in product development, fintech, IT consulting, and funding portals for clients like McDonalds, Deutsche Bank, and Citibank.

  • Alex Lee

    Alex Lee

    Director, Global Investments

    Extensive global investment experience across the entire capital stack, with in-depth knowledge of global capital markets and extensive network of institutional investors in Asia in particular. Prior experiences include prominent NY hedge fund and the largest banking group in Korea. 

Advisory Board

  • Richard Serbin, J.D.

    Chairman of the Board

    Global healthcare strategy advisor with over 40 years of service as FDA regulatory attorney and former VP of Corporate Development at Johnson & Johnson. Deep knowledge of international business. Extensive experience in serving on the Boards of Directors, transactional activities and advisory for governmental agencies in Brazil, Japan, Canada, and China.

  • Edward Rubin, J.D.

    Founder and President of RMA Venture Group, an advisory firm focusing on cross-border transactions among China and countries in North America, Europe, the former Soviet Union, and the Middle East; Former Founder and CEO of Rodman & Renshaw, a full-service investment bank with over 570 financings and US$14 billion raised while under Mr. Rubin's leadership.

  • German Kaplun, Ph.D.

    Partner at TMT Investments, a venture capital firm for the digital economy; Co-founder of RosBusinessConsulting, one of the largest Russian media groups in Russia; Co-Founder of Armada, top 5 largest Russian software companies. German is an M&A transactions and post-acquisition restructuring expert.

  • Yuri Mostovoy, Ph.D.

    Investment banker with 30+ years experience in international public and private business financing; Owner of Interval LLC, a company that develops advanced investment portfolio management systems; Chairman of the Board at TMT Investments

  • Haim Zitman

    Investment professional with 30+ years of experience and expertise in distressed M&A, enterprise crisis management and turnaround, debt restructuring and equity transactions. Mr. Zitman is a serial entrepreneur with extensive transactional experience on a global scale with a number of successful exits.

  • Andy Quinn

    Over 25 years of technology and healthcare education leadership experience. Co-founder of many cross-functional solutions and technologies addressing service gaps in healthcare, billing and compliance. In the past few years Andy has been CTO for Yingo Yango, and President of Broker Processing Service, he is also Chairman of NAFI, CT.

  • Ed Kanalosh, PhD, MD, MBA

    25 years of experience in investments, strategy consulting, commercialization, licensing and business development with the most recent assignments as a Partner in Life Sciences VC Fund Maxwell Biotech and Head of Investment Office of Skolkovo Foundation. Started career at Bill & Melinda Gates Foundation and then McKinsey. MBA from Harvard Business School.

  • Alexander Shneider, Ph.D.

    Founder and CEO of CureLab Oncology, Inc, co-founder and co-director of International Ph.D. Program in Life Science at University of Camerino, Italy, and Senior Research Fellow at University of Ariel, Israel. Author of multiple patents, books, and publications on topics ranging from business to biotechnology.